Navigation Links
Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
Date:8/12/2009

nical trials, address the increasingly urgent need for new treatments that target drug-resistant bacterial infections in the hospital and in the community. Cempra is well-funded and is committed to developing commercially viable products with consideration of pricing and reimbursement issues throughout the lifecycles of its products. The company is also using its proprietary chemistry technology to develop macrolides without antibacterial activity for uses related to motilin receptor activation, anti-inflammatory activity and GnRH receptor antagonism. Additional information about Cempra can be found at www.cempra.com.


'/>"/>
SOURCE Cempra Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
3. OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
4. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
5. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
6. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
7. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
8. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
9. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. ADVENTRX Pharmaceuticals Announces Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Colo. and THOUSAND OAKS, Calif., Dec. 14 /PRNewswire-FirstCall/ ... and Amgen Inc.(Nasdaq: AMGN ) today announced ... exclusive worldwide rights to Array,s small-molecule glucokinase activator ... Phase 1 clinical trial in patients with Type ... of the agreement, Array will receive an upfront ...
(Date:12/14/2009)... The third edition of ... published by the Infusion Nurses Society (INS), ... extravasation.(1) Anthracyclines are a group of chemotherapy ... have been used in the treatment of various ... ,, According to the INS publication: "In ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) ... announced public offering have exercised in full their ... common stock at the public offering price of ... option increases the size of the offering to ... Dendreon expects to receive net proceeds from ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... Alba Therapeutics Corporation,today announced the appointment of Bruce ... a member of its Board of Directors. Mr. ... Advisors, LLC. Previously, he served,as the CEO or ... for several,successful entrepreneurial healthcare companies operating in therapeutic,diagnostic ...
... 3, 2008 A policy comment in Science,today ... sites make explicit claims about the utility of ... by Genelex that,pharmacogenetic testing is "required to effectively ... is:, Paxil (paroxetine) is metabolized through CYP2D6. ...
... Agreement to Produce Reference Standard Reagents to ... ... Strategic,Diagnostics Inc. (Nasdaq: SDIX ) -- a leader in ... announced that it has,been selected by Science Applications International Corporation ...
Other Biology Technology:Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer 2Science Fuels DNA Testing Controversy with Prejudicial Misquote 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 3
(Date:12/15/2009)... 15 December 2009 - Scientists at VIB and Ghent ... for the treatment of septic shock, the major cause ... release of nitric oxide (NO) gas in mice with ... that the animal,s organs showed much less damage, while ... all expectations, since it is generally assumed that nitric ...
(Date:12/15/2009)... release is available in German ., ... everywhere across the globe, cultures vary as to how ... do not use egocentric terms such as ,left, right, ... allocentric notions like ,north, south, east, west, at all ... the bowl" or "There is an snake by your ...
(Date:12/15/2009)... German . , Leipzig: Species distribution models ... distribution of mammals. This is the finding of a ... mammals. The researchers analysed data on species distribution, climate, ... information of the species. Judging by the large differences ... seem to adapt fast to changing climatic conditions. This ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Species distribution models are of only limited value for predicting future mammal distributions 2Pesticides easier detection of pollution and impact in rivers 9791 1Pesticides easier detection of pollution and impact in rivers 9791 2GENova names Dr John Savin as Vice President 56261 1GENova names Dr John Savin as Vice President 56261 2Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index 56259 1Quest Diagnostics Marks Sixth Year on Dow Jones Sustainability Index 56259 2
... vote is partly genetic, according to a new study ... research, by James H. Fowler and Christopher T. Dawes, ... A. Baker, of the University of Southern California, is ... elections and in a wide range of political activities. ...
... and diving seabirds of the Southern Hemisphere unusually susceptible ... well as commercial fishing, mining, and oil and gas ... many species, according to P. Dee Boersma, of the ... issue of BioScience, Boersma provides a first-person ...
... the growth and development of plants, but what effect ... paper by Nathalie Hoang et al., published in ... examining cryptochromes in flies, mice, and humans. In plants, ... light for functions such as growth, seedling development, and ...
Other Biology News:Political participation is partially rooted in genetic inheritance 2Political participation is partially rooted in genetic inheritance 3A mammalian clock protein responds directly to light 2
...
... Optimization Kits without ammonium sulfate are compatible ... such as Taq and AmpliThem™™ DNA polymerases. ... PCR systems in one experiment by adding ... into the PreMixes supplied with the kit. ...
... FailSafe™ PCR System is the only PCR ... time and every time. It provides accuracy, ... the source or the property of the ... PCR Enzyme Mix, a unique blend of ...
Special grade: for molecular biology Density: 1.000 g/mL (20 C)...
Biology Products: